Additionally, with disease progression, there is significant reduction in cytosolic parkin levels in AD patient brain samples, which is indicative of inefficient mitophagy (Ye et al., 2015; Cai and Tammineni, 2016). Here, PRKN is linked to Alzheimer disease.